This one-day symposium, organized by the Swiss Chemical Society, Division Medicinal Chemistry and Chemical Biology, is dedicated to the theme «Strategies for Addressing Challenging Targets».

As the scientific community pushes the boundaries of drug discovery, certain biological targets remain notoriously difficult to tackle. Whether due to their structural complexity, dynamic nature, or elusive biochemical mechanisms, these challenging targets demand innovative approaches. The DMCCB Basel Symposium 2025 will bring together leading experts to explore cutting-edge strategies for overcoming these hurdles in drug discovery.

Join us on February 6, 2025, at the Biozentrum in Basel, where scientists from the fields of medicinal chemistry and chemical biology will meet to share the latest breakthroughs. From targeting protein-protein interactions to addressing the complexities of undruggable targets, this symposium promises a comprehensive overview of pioneering methods and techniques.

This event is designed to engage professionals and students alike, offering a platform for fruitful discussions and collaboration. Don’t miss this unique chance to be part of the conversation shaping the future of drug discovery and challenging target therapeutics.

Stefanie Flohr, Novartis
Sascha Hoogendoorn, University of Geneva
Pablo Rivera-Fuentes, Universität Zürich
Joseph Rogers, University of Copenhagen
Nicolas Thomä, EPFL Lausanne

To all participants, speakers and invited guests:
Please note that requests for any organizational issues will only be made by OC members of the event or the SCS Head Office (...@scg.ch). We do not collaborate with travel agencies that claim to book travel and accommodation on our behalf. In case of any uncertainty, please contact info@scg.ch and make sure that there is no fraudulent activity going on.